Chandigarh : The first meeting on Current Trends in Translational Research (CTTR-2023) concluded on 27th September in PGIMER, Chandigarh organized by the Department of Translational & Regenerative Medicine. The programme started with welcome of delegates by Dr. Aruna Rakha and introduction of 3D bioprinting and emphasized on its application in the clinics. Programme had talks from experts like Dr. Mukesh Gupta, National Institute of Technology (NIT) , Rourkela emphasizing role of tissue engineering and 3D bioprinting in spermatogenesis in infertility conditions followed by talk by Piyush Padmanabhan CEO, Next Innovation Big Labs (NIBL), Bengaluru on direct translational aspects of 3D bioprinting. Followed by workshop on 3D bioprinting, there were more talks emphasizing the role of bioprinting to meet the clinical needs (like in ophthalmic diseased conditions) in hospital-based system like PGIMER. 3D bioprinting is already been practiced in many hospitals to aid in surgical planning like in orthopaedic surgeries, 3D (bio)printing has the potential for so much more.
It is extensively been used in disease modelling but researchers and engineers are working hard and anticipate it can be the tool to solve the donor shortage problem by 3D bioprinting new organs in the future. Next day started with introduction of sequencing by Dr. Anupam Mittal and its application in modern day high-throughput sequencing. It was followed with an exciting workshop on Sequencing techniques and its application as a research tool. In the afternoon, symposium was inaugurated by Dr. RK Ratho, Sub-Dean (Research) and other dignitaries. The programme had exciting lectures on translational research by eminent scientists from Translational Health Science and Technology Institute (THSTI), Faridabad and PGIMER who emphasized on various aspects of clinically translational research applicable in field of Covid- 19, vaccine development and liver diseases.
The convenors of CTTR ’23 – Dr. Aruna Rakha, Dr. Anupam Mittal & Dr. Gaurav Sharma were immensely appreciated for putting up a wonderful scientific session which had utmost translational value bringing research from bench to bedside. The faculty of the department aspires to make the Department of Translational and Regenerative Medicine as a centre where they can move their research findings into therapeutics and to consider the insights from clinicians that are shaped into questions answered at the bench and within the clinical research environment.
